ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 683558 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 683558; 2) Community: the network communities that were significantly associated with the response to NSC 683558; 3) Molecule: the relationships between components within communities and NSC 683558; 4) MDR: the compounds that were significantly associated with the NSC 683558.

NSC Compound Enrichment Correlation
NSC 746513 5-Triazol-2-yl-methyl-2-[2?,(2??-chlorophenyl)-thiazolidin-4?-one-3?-yl]-1,3,4-oxadiazole 0.0152777849043084 0.16658689
NSC 747447 3,19-(4-N,N-dimethylamino)benzylidineandrographolide 0.0152777849043084 -0.11523169
NSC 93135 OXYACANTHINE 0.0152777849043084 0.18805811
NSC 135687 5.beta.-Bufa-20,22-dienolide, 14,15.beta.-epoxy-3.beta.,5-dihydroxy-, 3-acetate (8CI) 0.0164116791870034 0.37954243
NSC 144126 Null 0.0164116791870034 -0.0099547703
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.0164116791870034 0.32647764
NSC 263434 N,N'-Bis(3-methoxy-9-acridinyl)-1,8-octanediamine 0.0164116791870034 0.29274774
NSC 328410 Camptothecin Derivative 0.0164116791870034 0.7077884
NSC 606499 Camptothecin Derivative 0.0164116791870034 0.84100018
NSC 619030 Analog of CC-1065 0.0164116791870034 0.70671772
Total:71  Current:25    [First] [Prev] [Next] [Last]